Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

SV40 and human brain tumors.

E Geissler1, W Staneczek

  • 1Zentralinstitut für Krebsforschung und für Molekularbiologie, Akademie der Wissenschaften, DDR, Berlin-Buch.

Archiv Fur Geschwulstforschung
|January 1, 1988
PubMed
Summary

Polio vaccine recipients exposed to simian virus 40 (SV40) showed no increased tumor risk over 20 years. However, a potential increase in certain brain tumors may exist for those vaccinated with contaminated polio vaccine.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Primary cutaneous lymphoma-a case series of 163 patients].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2018
Same author

Static and dynamic behaviour of responsive graphene oxide-poly(N-isopropyl acrylamide) composite gels.

Soft matter·2016
Same author

Scaling behaviour of hyaluronic acid in solution with mono- and divalent ions.

Macromolecular symposia·2011
Same author

[Necrobiosis lipoidica. Variants on a theme].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2011
Same author

Dynamic scaling of polymer gels comprising nanoparticles.

The journal of physical chemistry. B·2007
Same author

X-ray intensity fluctuation spectroscopy by heterodyne detection.

Journal of synchrotron radiation·2006

Area of Science:

  • Oncology
  • Virology
  • Epidemiology

Background:

  • The simian virus 40 (SV40) is a polyomavirus that was found to contaminate polio vaccines administered between 1955 and 1963.
  • Concerns have been raised regarding the potential oncogenic effects of SV40 exposure in humans due to its presence in early polio vaccines.

Purpose of the Study:

  • To investigate the long-term cancer risk in individuals vaccinated with SV40-contaminated polio vaccines compared to those who received SV40-free vaccines.
  • To determine if there is an association between SV40 exposure from polio vaccination and the incidence of specific tumor types, particularly intracranial tumors.

Main Methods:

  • A retrospective cohort study design was employed to compare tumor incidence.
  • Follow-up of vaccinated individuals was conducted for up to 20 years post-vaccination.
  • Tumor data was analyzed based on vaccination status (SV40-contaminated vs. SV40-free vaccine).

Main Results:

  • No statistically significant increase in overall tumor development was observed in individuals who received SV40-contaminated polio vaccines compared to those who received SV40-free vaccines within the 20-year follow-up period.
  • An elevated frequency of certain intracranial tumors was suggested among individuals treated with the SV40-contaminated vaccine, although further investigation is warranted.

Conclusions:

  • The study suggests that SV40 contamination in early polio vaccines did not lead to a general increase in cancer risk over two decades.
  • A potential, albeit not definitively proven, association between SV40 exposure via polio vaccine and the development of specific brain tumors warrants further epidemiological research.

Related Experiment Videos